Professional
Added to YB: 2023-07-21
Pitch date: 2023-07-21
NLTX [bullish]
Neoleukin Therapeutics, Inc.
-0.29%
current return
Author Info
Special Situation Investments focuses on event-driven trades and low risk arbitrage opportunities with short term catalysts. Sign up for the newsletter.
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
As of December 18, 2023, Neoleukin Therapeutics, Inc. was acquired by Neurogene Inc., in a reverse merger transaction.
Market Cap
$32.8M
Pitch Price
$14.00
Price Target
N/A
Dividend
N/A
EV/EBITDA
1.22
P/E
-1.14
EV/Sales
N/A
Sector
Biotechnology
Category
N/A
Show full summary:
Neoleukin Therapeutics (NLTX) - Reverse Merger - Upside TBD
A summary for this pitch has not been created yet.
Read full article (1 min)